SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-010595
Filing Date
2020-05-13
Accepted
2020-05-13 16:34:30
Documents
54
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20200331b_10q.htm 10-Q 1058576
2 EXHIBIT 10.1 PAYROLL PROTECTION PROGRAM LOAN ex_185003.htm EX-10.1 74240
3 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_186198.htm EX-31.1 13212
4 EXHIBIT 31.2 CERTIFICATION OF CFO ex_186199.htm EX-31.2 15385
5 EXHIBIT 32.1 CERITICATION OF PERIODIC REPORT PURSUANT TO SECTION 302 CO-CEOS ex_186200.htm EX-32.1 9230
6 EXHIBIT 32.2 CERTIFICATION OF PERIODIC REPORT PURSUANT TO SECTION 301 CFO ex_186201.htm EX-32.2 6975
  Complete submission text file 0001437749-20-010595.txt   5238767

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT inbp-20200331.xml EX-101.INS 1205244
8 XBRL TAXONOMY EXTENSION SCHEMA inbp-20200331.xsd EX-101.SCH 48429
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20200331_cal.xml EX-101.CAL 46222
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20200331_def.xml EX-101.DEF 304118
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20200331_lab.xml EX-101.LAB 273196
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20200331_pre.xml EX-101.PRE 321857
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 20873654
SIC: 2834 Pharmaceutical Preparations